Antineoplastics: Cardiac impairment: 2 case reports.

This article from Reactions Weekly discusses two cases of cardiac impairment in patients with Ewing's sarcoma who were undergoing treatment with cyclophosphamide, doxorubicin, etoposide, ifosfamide, and vincristine. The patients developed adverse effects at 39 and 42 weeks into their treatment, leading to the discontinuation of chemotherapy. Despite this, both patients achieved complete remission of Ewing's sarcoma. [Extracted from the article]